SCHEMBL5720385

SCHEMBL5720385

O=C1[N]c2cc(C3CCN(C4CCN(Cc5ccccc5C(F)(F)F)CC4)CC3)ccc2N1

nearest known ligand 0.53

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.53
DRD2 P14416 1/20 0.51
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 6/20 0.49
C5AR1 P21730 3/20 0.44
ATM Q13315 2/20 0.42
NPSR1 Q6W5P4 2/20 0.41
TRPV6 Q9H1D0 3/20 0.41
KMT2A Q03164 1/20 0.40
PARP1 P09874 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
RECQL P46063 1/20 0.39
GAA P10253 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720125 0.87 CHRM1 (0.41) CHRM1DRD2KDM4EALDH1A1TRPV6
SCHEMBL5720092 0.86 CHRM1 (0.51) CHRM1DRD2KDM4EALDH1A1TRPV6
SCHEMBL5720263 0.84 CHRM1 (0.38) CHRM1DRD2KDM4EALDH1A1TRPV6
SCHEMBL5720312 0.84 DRD2 (0.40) CHRM1DRD2KDM4EALDH1A1TRPV6
SCHEMBL5720132 0.79 TRPV6 (0.41) CHRM1DRD2KDM4EALDH1A1TRPV6
SCHEMBL5719999 0.79 CHRM2 (0.45) DRD2ALDH1A1PARP1
SCHEMBL5720110 0.76 TLR9 (0.40) DRD2ALDH1A1
SCHEMBL5720388 0.76 DRD2 (0.40) DRD2KDM4ETRPV6PARP1
SCHEMBL5720128 0.76 TLR7 (0.44) DRD2ALDH1A1TRPV6PARP1
SCHEMBL4301270 0.76 SLC18A3 (0.48) CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP claimed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP claimed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO claimed